Search Tag: diagnostic imaging
2024 13 Mar
Affidea Group, the pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider, announces today its expansion in Switzerland, in the Canton of Aargau, in Baden, with the acquisitions of Röntgeninstitut Baden AG and AmbulanteGastroenterologie Baden AG. With more than 60 years of experience...Read more
2022 04 Oct
Dr. Puhlmann has over 20 years of oncology drug development experience and has spearheaded the global development and approval of multiple cancer drugs Viewpoint Molecular Targeting, Inc, a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents announced the...Read more
2022 06 Jun
The Company enters Valencia through the strategic acquisition of Tecma, a leading diagnostic imaging and outpatient care provider Affidea reaches 320 centers at European level, seeing over 10 million patients every year Tecma clinic is the leading private provider in Valencia region, offering diagnostic imaging, a wide range of outpatient...Read more
2022 10 Jan
Affidea , the largest European provider of diagnostic imaging, outpatient and cancer care services continues to invest in Italy and has today announced the 100% acquisition of Promea Center, a renowned outpatient provider in Piedmont region, Italy, specialized in outpatient services, day surgery and genetics. This acquisition is the first...Read more
2021 08 Oct
Affidea is delighted to announce the launch of two brand new outpatient clinics in Lithuania, in Panevėžys and Šiauliai, both of them designed with a patient centric approach, offering an outstanding and comfortable experience to all our customers. The two new centers will provide patients with high quality medical services in contract...Read more
2019 22 May
Affidea applies ground-breaking AI technology on Brain MRI examinations for people with Multiple Sclerosis Affidea has entered into a partnership with icometrix, a data science company that develops Artificial Intelligence (AI) solutions for healthcare, to standardise and improve the care of patients with neurological disorders. The official...Read more
2018 23 May
Affidea Group is a leading healthcare services provider with over 7500 professionals performing almost 13 million examinations each year. Affidea is recognised for its superior medical technology platform, scale efficiencies, internationally awarded medical excellence and its continued expansion into new ways to create value as an integrator provider...Read more
2018 23 May
Alliar’s innovative business model and IT systems mean that patients in remote locations have access to standardised, high-quality exams in any of its patient centres across Brazil. Intro: Parauapebas Parauapebas is a small town located in north Brazil, next to the Amazon rainforest. It sits 2,000 km away from São Paulo, the country’s...Read more
2015 08 Aug
In a manifesto, a group of eminent oncologists note how the steep prices of cancer drugs are affecting the care of patients with cancer. They cite data showing that in 2014 all new FDA-approved cancer drugs were priced above $120,000 per year of use. They are calling for a reduction in drug prices. While the skyrocketing drug prices may be driving...Read more